Ananda Ghosh
Stock Analyst at H.C. Wainwright
(3.71)
# 2,079
Out of 5,076 analysts
127
Total ratings
38.2%
Success rate
7.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ananda Ghosh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MAZE Maze Therapeutics | Maintained: Buy | $110 | $32.45 | +238.98% | 23 | Oct 21, 2026 | |
| ANNX Annexon | Reiterated: Buy | $14 → $25 | $3.83 | +552.74% | 10 | Oct 19, 2026 | |
| IBIO iBio, Inc. | Reiterated: Buy | $7 | $0.821 | +752.62% | 2 | Oct 2, 2026 | |
| PRQR ProQR Therapeutics | Reiterated: Buy | $12 → $8 | $1.38 | +479.71% | 11 | Oct 1, 2026 | |
| ACAD Acadia Pharmaceuticals | Reiterated: Buy | $37 → $33 | $20.44 | +61.45% | 15 | Sep 25, 2026 | |
| GPCR Structure Therapeutics | Reiterated: Buy | $70 | $22.88 | +205.94% | 21 | Sep 9, 2026 | |
| PEPG PepGen | Reiterated: Buy | $20 | $2.87 | +596.86% | 14 | Sep 9, 2026 | |
| STOK Stoke Therapeutics | Reiterated: Buy | $50 | $26.61 | +87.90% | 11 | Aug 4, 2026 | |
| DYN Dyne Therapeutics | Reiterated: Buy | $50 | $16.27 | +207.31% | 9 | May 21, 2026 | |
| SKYE Skye Bioscience | Reiterated: Buy | $160 | $1.62 | +9,776.54% | 7 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $3.26 | +636.20% | 4 | Jan 28, 2026 |
Maze Therapeutics
Oct 21, 2026
Maintained: Buy
Price Target: $110
Current: $32.45
Upside: +238.98%
Annexon
Oct 19, 2026
Reiterated: Buy
Price Target: $14 → $25
Current: $3.83
Upside: +552.74%
iBio, Inc.
Oct 2, 2026
Reiterated: Buy
Price Target: $7
Current: $0.821
Upside: +752.62%
ProQR Therapeutics
Oct 1, 2026
Reiterated: Buy
Price Target: $12 → $8
Current: $1.38
Upside: +479.71%
Acadia Pharmaceuticals
Sep 25, 2026
Reiterated: Buy
Price Target: $37 → $33
Current: $20.44
Upside: +61.45%
Structure Therapeutics
Sep 9, 2026
Reiterated: Buy
Price Target: $70
Current: $22.88
Upside: +205.94%
PepGen
Sep 9, 2026
Reiterated: Buy
Price Target: $20
Current: $2.87
Upside: +596.86%
Stoke Therapeutics
Aug 4, 2026
Reiterated: Buy
Price Target: $50
Current: $26.61
Upside: +87.90%
Dyne Therapeutics
May 21, 2026
Reiterated: Buy
Price Target: $50
Current: $16.27
Upside: +207.31%
Skye Bioscience
May 21, 2026
Reiterated: Buy
Price Target: $160
Current: $1.62
Upside: +9,776.54%
Jan 28, 2026
Reiterated: Buy
Price Target: $24
Current: $3.26
Upside: +636.20%